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Mitochondrial cytochrome c is associated with electron transfer in the respiratory chain and 
in apoptosis. Four cytochrome c variants have been identified in families that suffer from 
mild autosomal dominant thrombocytopenia, a platelet disorder associated with increased 
apoptosis. Three out of the four substitutions, G41S, Y48H and A51V are located on the 40-
57 -loop. The G41S and Y48H variants perturb key physicochemical and dynamic 
properties that result in enhanced functional features associated with apoptotic activity. 
Herein we characterise the ferric A51V variant. We show by chemical denaturation that this 
variant causes the native state to be destabilized. Through azide binding kinetics, the 
population of a pentacoordinate heme form, whereby the Met80 axial ligand is dissociated, is 
estimated to be of equal magnitude to that found in the Y48H variant. This pentacoordinate 
form gives rise to peroxidase activity, which despite the similar pentacoordinate population 
of the A51V variant to that of the Y48H variant, the peroxidase activity of the A51V variant 
is supressed. Far-UV circular dichroism spectroscopy and pH jump studies, suggest that a 
combination of structural and dynamic features in addition to the population of the 
pentacoordinate form regulate peroxidase activity in these disease variants. Additionally, the 
steady-state ratio of ferric/ferrous cytochrome c when in turnover with cytochrome c oxidase 
has been investigated for all 40-57 -loop variants. These studies show that the lower pKa of 
the alkaline transition for the disease causing variants increases the ferric to ferrous heme 
ratio, indicating a possible influence on respiration in vivo.  
 
















Mitochondrial cytochrome c (Cc) is a key protein in the life and death processes of a 
eukaryotic cell. In humans, it is now widely recognised that Cc has an extensive repertoire of 
roles ranging from acting as an electron shuttle in oxidative phosphorylation to roles in 
apoptosis, redox signalling, as an inhibitor of histone chaperone activity and an involvement 
in the mitochondrial oxidative folding machinery.[1-4] These multiple functions have led to 
Cc being branded as an extreme multifunctional (EMF) protein.[5, 6]  
 Cc possesses a hexacoordinate heme, with axial heme iron coordination derived from 
the N
1
 atom of His18 and the S

 atom of Met80.[7] The c-type heme is bound to the 
polypeptide through a CXXCH motif within a fold that comprises of five -helices, and three 
-loops[7] (structural motifs with residues at the start and end of the loop close in space [8, 
9]). Embedded in the EMF persona of Cc is its ability to access energetically favoured 
conformational states above its ground state native structure.[5] Under physiological 
conditions the ferric form of Cc exists in an equilibrium between the dominant 
hexacoordinate form and a minor populated pentacoordinate state, in which the Met80 ligand 
is dissociated from the heme iron.[7] Despite the pentacoordinate population being 
exceedingly low, it is sufficient to confer peroxidase activity,[10-15] which has implications 
for apoptotic activity, in particular when Cc is complexed with the phospholipid cardiolipin 
(CL).[16-24]  
At alkaline pH, ferric Cc can access a conformational state whereby a deprotonation 
of a group within a hydrogen bonded network of amino acid side chains and a heme 
propionate causes dissociation of the Met80 ligand [25] and subsequent coordination to the 
heme iron by a Lys residue from the 71-85 -loop.[25-28] This transition is commonly 
referred to as the alkaline transition and when measured under equilibrium conditions has an 
apparent pKa of ~ 9 depending on solution conditions and Cc species.[7, 29, 30] A common 
feature in formation of these non-native conformers of ferric Cc is a dynamic communication 
between the 40-57 and 71-85 -loops.[5, 25, 31, 32] These two structural units have been 
shown to possess the lowest free energy out of the five cooperative folding/unfolding units 
(foldons) assigned in Cc, with the 40-57 -loop having the lowest stability.[33-36] 
Furthermore, the Fe(III)-S(Met80) bond strength, a key regulator to accessing the non-native 
states, is influenced by an entatic contribution of the protein derived through a hydrogen 












hydrogen bonding network diminishes the entatic control and enhances Met80 
dissociation.[25, 37]  
Four pathogenic mutations in the human Cc gene have been identified in families that 
suffer from mild autosomal dominant thrombocytopenia (THC4; OMIM 612004); a disorder 
caused by dysregulated platelet formation associated with increased mitochondrial 
apoptosis.[38-41] Three of the mutations are missense and give rise to the G41S, Y48H and 
A51V variants found in the 40-57 -loop,[38-40] with the fourth an in-frame deletion that 
results in a variant whereby Lys100 in the C-terminal -helix is deleted[41] (Fig. 1). The 
G41S variant possesses enhanced apoptotic activity in vitro,[38] with subsequent studies 
providing further insights into the physicochemical properties inherent in this variant 
attributing to enhancing apoptotic activity.[23, 24, 31, 42, 43] Of particular note is an 
increased population of the pentacoordinate heme form under non-denaturing conditions.[23, 
31] Enhanced apoptotic activity of the Y48H variant was initially reported,[39] with a more 
detailed in vitro characterisation revealing the Y48H variant to have substantially higher 
peroxidase activity than the G41S variant, attributed to the equilibrium between the 
hexacoordinate and pentacoordinate heme forms being shifted further towards the 
pentacoordinate state.[5] Solution NMR spectroscopy studies on these variants demonstrated 
that main chain dynamics were enhanced compared to wild-type (WT) human Cc (hCc).[5, 
31] Notably, the dynamic hot spots are centred around the 40-57 and 71-85 -loops with a 
dynamic hierarchy of Y48H > G41S > WT, which currently scales with the population of the 
pentacoordinate species associated with peroxidase activity.[5, 31]  
 In the present study we have prepared the A51V variant to ascertain the properties 
this mutation infers on the functional properties of hCc and to place the findings in context 
with our previous studies with the G41S and Y48H variants.[5, 25, 31] We have performed a 
suite of experiments designed to probe the pentacoordinate form of the native state that gives 
rise to the peroxidase activity. We find that the A51V variant has a relatively mild effect on 
the physicochemical properties of hCc. However, despite the population of the 
pentacoordinate heme species being enhanced, the peroxidase activity remains supressed 
compared to the G41S and Y48H variants. Furthermore, we have investigated the effects of 
the three 40-57 -loop variants on the redox state of hCc in steady-state turnover with 
cytochrome c oxidase (CcO). In these turnover experiments the redox state of hCc was 
affected by the nature of the substitution, with Y48H having the larger effect and the A51V 













MATERIALS AND METHODS 
Construction of the A51V hCc variant 
The A51V variant of hCc was constructed using the Quikchange mutagenesis (Stratagene) 
protocol with the pUC19hCc plasmid as template.[23] The forward and reverse mutagenic 
primers were as follows: 5’-CTCTTACACAGCCGtgAATAAGAACAAAG 3’ and 5’- 
CTTTGTTCTTATTcaCGGCTGTGTAAGAG-3’, respectively, with the mutation sites in 
lower case. A PCR mix consisting of primers (75 ng/µl), pUC19hCc (15 ng/µl), 10 mM 
dNTPs (Fermentas), Pfu (Pyrococcus furiosus) Turbo polymerase (Agilent), 10x polymerase 
buffer (Agilent) and deionised water to give a final volume of 50 l and subjected to the 
following PCR cycle; 95 °C – 3 min, (95 °C – 1 min, 65 °C – 1 min, 72 °C – 6 min) x 18, 72 
°C – 10 min. PCR products were digested with the restriction enzyme DpnI (Fermentas) and 
transformed into Escherichia coli XL1-Blue (Agilent) cells. DNA sequencing was used to 
confirm the presence of the desired nucleotide changes (Source BioScience, UK).  
 
Over-expression of hCc and variants 
Over-expression of WT hCc, the G41S, Y48H and A51V variants was carried out in E. coli 
strain BL21(DE3)-RIL (Agilent) with isolation and purification of all proteins as reported 
previously.[23]  
 
Isolation and purification of bovine CcO 
A fresh bovine heart was obtained from C.J. Byford & Sons (Clacton-on-Sea, U.K.) and CcO 
was isolated according to a previously reported procedure.[44] The pure CcO, as judged by 
the absorbance ratio 445/420 nm in the reduced state of > 2.5, was aliquoted and stored in 






Oxidized Cc proteins were prepared by the addition of excess K3[Fe(CN)6], followed by 
removal of K3[Fe(CN)6] and K4[Fe(CN)6] and exchanged into a desired buffer using a PD-10 
column (GE Healthcare). Protein concentrations were determined using a Cary 60 
spectrophotometer (Agilent). Molar extinction coefficients () were determined for ferric WT 












Aliquots of CcO were thawed and spun for 2-3 min at high speed in a micro-centrifuge. The 




) in the reduced CcO samples arising from 
heme a was used to determine sample concentration. All CcO concentrations are expressed in 
terms of heme a concentration.  
 
Far-UV circular dichroism spectroscopy and chemical denaturation  
Far-UV circular dichroism (CD) spectroscopy was carried out using an Applied Photophysics 
Chirascan CD spectrophotometer (Leatherhead, UK) thermostatted at either 15 or 20 
o
C. 
Ferric protein samples (18-26 M) were prepared in 10 mM potassium phosphate, 50 mM 
potassium fluoride pH 6.5 and a wavelength scan between 190-250 nm was conducted. To 
determine protein stability, a 6 M stock solution of guanidine hydrochloride (GuHCl) (Fluka) 
was prepared in the identical buffer and titrated into a ferric A51V variant sample. Changes 
in molar ellipticity at 222 nm (222nm) were monitored and the free energy of unfolding 
(Gunf) and dependence of Gunf on denaturant concentration (m-value) were calculated using 











  (1) 
 
where N and D correspond to the baseline values of the native and denatured protein at 0 M 
GuHCl respectively, and N and D to their respective dependence on [GuHCl] i.e. the slope. 
Gunf is the free energy of denaturation in water and m represents the dependence of the free 
energy of denaturation on [GuHCl]. To represent the data in terms of fraction denatured (FD) 





   (2) 
 
All titrations were carried out in triplicate with the errors reported the standard error. 
 
Alkaline pH titrations 
The pH dependence of the 695 nm band in the electronic absorption spectrum of the ferric 
A51V hCc variant (100 M) was monitored at 25 
o












at various values of pH in the presence of a small aliquot of K3[Fe(CN)6] to maintain an 
oxidising environment. The pH of the buffer (20 mM sodium phosphate pH 6.0) was adjusted 
with microliter aliquots of 1 M NaOH and measured after each addition using a semi-micro 
glass pH electrode. pH titrations were repeated three times and with different batches of 




The oxidation of 2,2-Azinobis(3-ethylbenthiazoline-6-sulfonic acid) (ABTS; Fisher) was 
monitored at 730 nm on a Hewlett-Packard 8453 diode-array spectrophotometer scanning 
between 190 and 1100 nm and thermostatted at 20 
o
C. The reaction was initiated by the 
addition of 1 mM H2O2 (after 40 s) to a series of cuvettes containing 5 M of the ferric A51V 
variant and 200 M ABTS. Using the wavelength pair 475-730 nm the slope of each trace 
(post-lag phase) was determined to obtain a rate in AU/s. The turnover rate is reported in s
-1
 





) and the total protein concentration (5 M). All assays were carried out in triplicate with 
errors reported as the standard error. 
 
Azide binding kinetics 
An Applied Photophysics (Leatherhead, UK) SX20 stopped-flow spectrophotometer 
thermostatted at 25 
o
C and equipped with both photomultiplier and diode array detection 
systems was used to monitor rapid reaction kinetics. A stock solution of 2 M sodium azide 
(N3
–
 ; Sigma-Aldrich) was buffered in 50 mM 2-(N-morpholino)ethanesulfonic acid (MES) 
pH 7.0 and diluted to the desired [N3
–
] with the same buffer containing 2 M NaCl to maintain 
the ionic strength. Reaction time-courses were taken at 420 nm with [N3
–
] varying between 
0.08 and 2 M (before mixing) and 10 M protein (before mixing). All transients were fitted 
to a single exponential function yielding both pseudo first-order rate constants and 
amplitudes. Assuming N3
–
 binding to ferric Cc is an SN1 mechanism, in which the 
hexacoordinate heme form is in equilibrium with a pentacoordinate form, the latter being the 
form that binds N3
–
, then, as outlined previously,[31] equations 3 and 4 may be derived that 
describe the Kapp and the dependence of kobs for N3
–




























+ 𝑘−2  (4) 
 
In these equations, K = k1/k-1, where k1 and k-1 are the rate constants for Met80 dissociation 
and association respectively and KD = k-2/k2, with k2 the pseudo-first order rate constant for 
N3
–
 binding i.e. k2 = k'[N3
–
], where k' is the second order rate constant and kobs is ~ k1 at high 
[N3
–
]. The data for the A51V and Y48H variants were not collected over a sufficiently wide 
range to allow for the fitting algorithm to converge and yield values for the three parameters 
defining equation 4. However, convergence was achieved to yield values of k-2 (the intercept 
on the ordinate), which was then fixed and not allowed to vary, to determine k1 with its 
associated errors. In addition calculation of k1 using either the upper or lower bound error for 
k-2 were used and these values are discussed in the footnote to Table 2. 
 
pH jump kinetics 
For pH jumping experiments a range of pH buffers containing 50 mM KCl, 50 mM boric acid 
(pH 7 - 9) or 50 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) (pH 9 - 13) were 
prepared and stocks of the ferric A51V variant prepared in H2O and diluted to experimental 
concentrations in 50 mM KCl, to maintain ionic strength during mixing, to a pH of ~ 7. pH 
jump experiments were initiated in a stopped-flow spectrophotometer by mixing solutions of 
the ferric A51V variant with an equal volume of high pH buffer. First order rate constants 
(kobs) were obtained by fitting reaction time-courses to either a single exponential at pH 
values between 8.5 and 10 (kobs1 slow phase) or at pH values above 10.5 a double exponential 
function (kobs1 and kobs2 fast phase). Experiments were repeated in triplicate and with different 
protein batches with errors reported the standard error. All kinetic analysis was conducted 
using the software ProKineticist (Applied Photophysics).  
 
Turnover experiments using cytochrome c oxidase 
Kinetic experiments were carried out using a stopped-flow spectrophotometer operating in 
photo diode array mode. CcO (5 µM), ferric h Cc (20 µM), sodium ascorbate (10 mM; 
Sigma-Aldrich) and the redox mediator N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD 
concentrations ranging between 100 to 600 µM; Fisher) were dissolved in 0.1 M sodium 
phosphate buffer, pH 7.4, containing 1% Tween 80 (Sigma-Aldrich). This solution rapidly 












CuB) before rapidly mixing with aerobic buffer (~270 µM oxygen as determined from the 
solubility coefficient using the temperature and pressure on the day). On mixing, the reduced 
CcO is fully oxidised within the dead time of the stopped-flow (~ 1.5 ms) and thereafter a 
sequence of reactions occur (see Results) that leads eventually to the complete depletion of 
oxygen and the return of the system to the fully reduced state. The excursions of the spectral 
absorption bands associated with the chromophores present were followed using a diode 
array accessory and time courses and levels of reduction in steady-state monitored. 
 
RESULTS 
Far-UV CD spectroscopy of the ferric A51V variant and comparison with the G41S and 
Y48H hCc variants 
The far-UV CD profile for ferric hCc is shown in Figure 2A, with the characteristic minima 
at 208 and 222 nm consistent with a fully folded protein dominated by -helical structure. 
The ferric A51V variant displays a similar profile, as do the G41S and Y48H variants, 
confirming in the first instance that on purification the A51V variant is folded (Fig. 2A). No 
differences in the far-UV CD profiles for the WT or any of the variants in a temperature 
range between 10 and 30 
o
C were observed (data not shown). The X-ray structures of the 
three variants, [5, 42, 48], reveal no significant secondary structure differences in respect to 
the WT structure.[23] In contrast, solution NMR studies indicate that the G41S and Y48H 
variants are more dynamic than the WT protein.[5, 31] In this respect, we note that the 222/208 
nm ratio between the variants varies from the WT protein (Fig. 2A). For the WT protein, the 
222/208 nm ratio is 1.3, with a value of 1.1 determined for the G41S and A51V variants and the 
Y48H variant having a ratio of 0.9. For a globular -helical protein, perturbations to the 
222/208 nm ratio can be associated with changes in interhelical interactions resulting from 
changes to the packing of Trp side chains within a protein core [49]. In Cc, Trp59 has a key 
role in the packing of the Cc hydrophobic core.[50] Therefore, the 222/208 nm ratio hierarchy 
(WT > G41S  A51V > Y48H) may infer differences in packing around Trp59, arising from 
the increased global dynamics reported from NMR studies for the G41S and Y48H 
variants,[5, 31] and therefore a similar increase in dynamics could be anticipated for the 
A51V variant.  
 












The thermodynamic unfolding parameters for the ferric A51V variant were obtained by 
monitoring the decrease in  at 222 nm in the far-UV CD spectrum upon titration with 
GuHCl. The conditions employed (pH 6.5 and 15 
o
C) were identical to those used previously 
for the G41S and Y48H variants for which the free energy changes were used in conjunction 
with NMR H/D-exchange data collected at 15 
o
C.[5] Table 1 reports the Gunf, m-value and 
Cm values for the ferric A51V variant and a plot of the fraction unfolded versus [GuHCl] is 
shown in Fig. 2B. It is apparent from Table 1, that the global stability of the ferric A51V 
variant follows a similar trend to both the G41S and Y48H variants, in that the cooperativity 
of unfolding (m-value) decreases, leading to a decrease in the Gunf, with respect to WT hCc. 
As noted previously,[5] the introduction of a His residue in the Y48H variant has 
connotations to the possibility of it competing with His26 and His33 in ligating to the heme 
iron in the denatured state. Therefore, a comparison of the stability (Gunf) amongst the 
three variants is made using GuHCl at a pH where additional competing misligation in the 
denatured state for the Y48H protein is a possibility (Table 1). However, from the Gunf a 
hierarchy of global stability for the 40-57 -loop variants of WT >> A51V  G41S >> Y48H 
is observed, with a parity between the A51V and G41S variants and the Y48H variant being 
the outlier. 
 
Effect on the local stability of the 71-85 -loop imposed by the A51V hCc variant 
From previous work with the ferric G41S and Y48H variants, we have shown that mutations 
in the 40-57 -loop influence the structural dynamics of the Met80-containing -loop, with 
consequences for the Fe(III)-S(Met80) bond lability.[5, 31] Our preference has been to 
investigate the local dynamics of the 71-85 -loop by using the kinetics of N3
–
 binding.[5, 
25, 31] Such experiments provide an insight into the population of the pentacoordinate heme 
form i.e. the Met80-off form that binds N3
–
 and gives rise to the intrinsic peroxidase activity. 
Upon mixing N3
–
 with the ferric A51V variant, an optical transition occurs caused by 
dissociation of the Met80 ligand from the heme iron and binding of N3
–
 in its place.[31] The 
reaction time-course of this transition for the A51V variant conformed to a simple 
exponential as reported for other hCc variants under identical experimental conditions. [5, 25, 
31] The normalised amplitudes of the reaction time-courses over a broad range of [N3
–
] 
follows a simple hyperbolic relationship, enabling an apparent equilibrium constant (Kapp) for 
N3
–
 binding to be determined (Fig. 3A). The Kapp for the ferric A51V variant is reported in 












Notably, the A51V variant has a Kapp identical to the Y48H variant. The relationship between 
the rate constant for N3
–
 binding (kobs) and [N3
–
] given in equation 4 should conform to a 
hyperbola, where a curve is expected to reach a plateau (i.e. k1, the Met80 ligand dissociation 
rate constant). As previously discussed for WT hCc and the G41S and Y48H variants this is 
not the case under the conditions employed, as a suitably high [N3
–
] cannot be explored.[5, 
25, 31] Earlier work using linear fitting procedures used reciprocals to obtained k1 values of 
30 s
-1
 for horse heart Cc using N3
–
 as the competing ligand.[51] Refitting of this earlier data 
using equation 4 (non-linear fitting) gives a value of between 11-16 s
-1
 for horse heart Cc 
[31] which is comparable to that of WT hCc (Table 1). A non-linear fit to the data for the 
A51V variant is shown in Figure 3B and yields the k1 and k-2 values reported in Table 1. A 
comparison of the k1 and k-2 values reported previously for the WT, G41S and Y48H variants 
reveals the k1 of the Met80 ligand for the A51V variant is elevated above the WT hCc and 
lies closer to the G41S variant, rather than the Y48H variant (Table 1). 
 Equation 3 shows that when K < 1, as seen here, because the concentration of the 
pentacoordinate species is low, then Kapp is ~ KD/K. Based on the assumption that N3
–
 binding 
to the pentacoordinate heme species is not influenc d directly by the different substitutions in 
the protein other than by the provision of pentacoordinate ferric heme, then KD will be similar 




Kapp, reflects the ratio 




K and therefore is indicative of the relative proportions of the 
pentacoordinate heme state. We have justified the assumption that the heme in the WT hCc 
and variants have the same intrinsic KD in our previous work and have proposed that the 
differences between the WT and variants reflect the different extent to which the protein 
matrix cages the heme group from the approach of the ligands.[25] This justification is based 
on the fact that the measured off-rate of the N3
–
 (k-2) and the Met80-off rate (k1) for the 
disease variants conforms to a hyperbola, asymptotic to 11.8 ± 0.6 s
-1
 (Fig. 3C). As this value 
is only reached when Met80 is essentially dissociated it constitutes the intrinsic dissociation 
rate constant, k-2 intrinsic, of N3
–
 dissociating from the heme in these hCc variants. As the 
A51V variant falls neatly on the same hyperbolic relationship we conclude this variant 
likewise has the same intrinsic KD (Fig. 3C). Therefore based on these previous 
arguments,[25] the A51V variant has a pentacoordinate heme state populated to essentially 
the same extent as the Y48H variant as determined from N3
–


















The intrinsic peroxidase activity of Cc arises from the existence of an equilibrium in the 
ferric heme state between the hexacoordinate Met80-bound form and a pentacoordinate 
Met80-off form, with the latter being peroxidase active.[7, 10-15] In the early stages of 
apoptosis, CL complexes with Cc, resulting in the pentacoordinate form becoming dominant, 
enabling oxidation of CL to occur.[16] A feature of the 40-57 -loop variants has been their 
increased intrinsic peroxidase activity relative to WT hCc.[5, 23, 24] Under identical assay 
conditions to previous studies with the G41S and Y48H variants,[5] the A51V variant is 
capable of oxidizing ABTS in the presence of H2O2, with a turnover lower than that of the 
G41S variant, but greater than for the WT protein (Fig. 4). Notably, the apparent equivalent 
population of the pentacoordinate species for the A51V and Y48H variants deduced from N3
–
 
binding kinetics does not manifest itself in the intrinsic peroxidase activity of these two 
variants (Fig. 4), with the A51V variant having peroxidase activity closer to the WT and 
G41S variant than the Y48H variant. 
 
Alkaline isomerisation and pH jump kinetics of the ferric A51V hCc variant 
The 695 nm absorbance band in the electronic absorption spectrum of ferric hCc reports on 
the presence of the Met80(S)-Fe(III) heme bond.[7, 52] It is well established that as the pH 
increases towards alkalinity, a bleaching of the 695 nm band is observed that is a 
consequence of the dissociation of a single proton resulting in the dissociation of the Met80 
heme ligand and replacement by a Lys residue found in the 71-85 -loop.[25-28, 53] The 
Lys bound form of Cc is referred to as the alkaline conformer.[53] For the A51V variant the 
apparent pKa for the alkaline conformer, determined by monitoring the bleaching of the 
absorbance band at 695 nm is 8.3 ± 0.1 (Fig. 5A), similar to the decrease of ~ 1 pH unit 
compared with WT hCc seen with the G41S and Y48H variants (Table 2). Thus, the three 
disease causing variants each stabilize the alkaline conformer to a similar degree relative to 
the WT protein. 
 The kinetics of the alkaline transition in mitochondrial Cc have been extensively 
studied and the mechanistic features can be described by a simple model depicted in Scheme 
1, whereby deprotonation of a group termed the trigger (pKH1), initiates a conformational 
















In Scheme 1, 
h
Cc-Htrig depicts the His/Met hexacoordinate protein with the trigger 
protonated, 
h
Cc the His/Met hexacoordinate protein with the trigger deprotonated, and 
h
Cc-
Lys the hexacoordinate alkaline conformer of Cc with Lys now coordinated. KH1 and Kc are 
the equilibrium constants for the protonation/deprotonation and the conformational change, 
respectively, and kf1 and kb1 are the forward and backward rate constants, respectively. The 
ferric A51V variant was subjected to a series of stopped-flow pH jump experiments in the pH 
range 7.0 to 10.0. where a single spectral transition was observed with the Soret band blue-
shifted and the 695 nm band bleached. We have adopted an analysis in which the full data set 
is subjected to singular value decomposition with no evidence for more than one phase. The 
transition therefore could be adequately fitted to a single exponential phase, with the 
determined rate constants (kobs1) increasing as expected with increasing pH (Fig. 5B). Similar 
behaviour has been previously reported for WT hCc and the G41S and Y48H variants.[25] 
Based on the model in Scheme 1, equation 5   
 
kobs1 = kb1 + kf1 (
KH1
KH1+H+
)   (5) 
 
can be used to fit the titration curve displayed by the A51V variant in Fig. 5B to yield the 
pKH1 of the trigger. In equation 5, kobs1 takes the value kb1 at low pH and kb1 + kf1 at high pH 
values. The kf1 and pKH1 values for the A51V variant determined from the experimental data 
are reported in Table 2, and kb1 values have been estimated due to the difficulties in directly 
obtaining accurate values (as was also the case in previous work[25]). Comparison of the kf1 
and pKH1 values for the A51V variant with those determined for WT hCc and the G41S and 
Y48H variants are reported in Table 2, where it is apparent that the A51V variant lowers the 
pKH1 of the trigger by > 1 pH unit as noted with the other disease associated variants.[25] 
However, the pKH1 value for the A51V variant is slightly higher relative to the G41S and 
Y48H variants, but nevertheless continues the trend of substitutions in the 40-57 -loop for 
making the trigger substantially easier to deprotonate. 
 At higher pH values (> 10) a second rapid phase (kobs2), in addition to the slow phase 
(kobs1) has been reported for hCc, several of its variants and horse heart Cc.[25, 55-58] For 
the A51V variant this rapid phase is also observed (Fig. 6A). The rate constant, kobs2, is 












heme species having a prominent band at ~ 600 nm (Fig. 6B) and possessing long 
wavelength features that obscure the bleaching of the 695 nm band at some pH values. The 
spectrum decays to a final low-spin form typical of a ferric heme species with a Lys/His 
coordination (Fig 6B). It is notable for the A51V variant that this HS species is populated to a 
lesser extent than either the G41S and Y48H variants.[25] The kobs2 values decrease for the 
A51V variant until ~ pH 11, before rising steeply (Fig. 5C). At the lower pH values, the 
decrease in kobs2 values observed for the A51V variant is reminiscent of the WT protein (Fig. 
5C), rather than the G41S and Y48H variants, where kobs2 values increase from pH 10 and 
above (Fig. 5C). Above pH 11 the A51V variant behaves as the G41S and Y48H variants. 
The increasing kobs2 values for the G41S and Y48H variants implies that deprotonation 
precedes the conformational change that leads to the dissociation of the Met80 ligand from 
the heme iron.[25] This behaviour has been assigned to a coupling between a conformational 
change that exposes a group (not the trigger) that then undergoes deprotonation leading to the 





In Scheme 2, -H represents the non-exposed group in the hexacoordinate His/Met form (
h
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Cc representing the deprotonated HS heme form. Thus the A51V variant appears to be 
a combination of both the WT hCc (in the lower pH range) and the G41S and Y48H variants 
in the higher pH range, except that the pKH2 calculated for the G41S and Y48H variants of 
11.0 [25] is shifted to a higher value (~ 11.5) for the A51V variant. It should be noted for WT 
hCc the pKH2 cannot be calculated as the kobs2 values obtained at pH values > 12.5 are 
obscured by a more general denaturation of the protein as commented on previously.[25]  
 
Steady-state kinetics of CcO with the three THC4 causing 40-57 -loop variants 
The respiratory function of Cc requires it to carry an electron from cytochrome c reductase 
(complex III) and deliver it to CcO (complex IV). Electrons enter the dinuclear CuA site of 
CcO and are passed to heme a and then to heme a3 and finally CuB, where a dioxygen 












physiological pH, one might expect that lowering the pKa value from ~ 9.3 (WT hCc [5]) to ~ 
8.4 (G41S and Y48H variants [5]) would lead to an increase in the fraction of the ferric Cc in 
the alkaline, non-reducible form, and therefore to a change in the steady-state ratio of 
ferric/ferrous Cc when this is in turnover with its natural partner, CcO. To assess whether this 
is the case for the disease variants a series of steady-state experiments have been undertaken. 
These experiments monitor the redox state of WT hCc and variants while in turnover, 
receiving electrons from ascorbate/TMPD and donating these electrons to CcO and thence to 
oxygen. The methodology employed ensures that fully oxidised, activated (“pulsed”) CcO is 
presented with fully reduced hCc in the presence of oxygen and a reductant system (sodium 
ascorbate and the mediator TMPD).[61] Figure 7A shows the result of such an experiment 
and displays spectra collected at known times. By increasing the rate of WT hCc reduction by 
ascorbate through addition of higher concentrations of TMPD, the steady-state reduction 
level of the whole system may be adjusted (Fig. S1). In Fig. 7A the spectra shown 
demonstrate that initially WT hCc is fully reduced and then rapidly donates electrons to 
oxidized CcO. The system now enters into steady-state (between 2 - 22 s) in which hCc is 
held at ~ 40 % reduced during turnover (Fig. 7A and Fig. S1). Once the oxygen present is 
depleted, WT hCc (and CcO) is returned to the fully reduced state (31 s) by the excess 
reductant (Fig. 7A). The time course followed at 550 nm, the α band of ferrous hCc, is shown 
in Figure 7B and reports that the redox state of hCc remains almost constant between 2 and 
22 s, i.e. from the time the system enters steady-state until oxygen is exhausted (Fig. 7B). 
Closer examination, however, reveals that during this time there is a small decrease in the 
level of reduced WT hCc. This is better seen in the difference spectra shown in Fig. 7C in 
which the spectrum collected at 22 s is subtracted from that collected at 2 s. This difference 
spectrum is that of reduced minus oxidised WT hCc and shows that approximately 1.5 % of 
the protein became ferric in the time of the steady-state (between 2 and 22 s).  
The same experiment was conducted using the G41S, Y48H and the A51V variants, 
and gave similar overall results but showed that in the variants the shift towards the ferric 
form was enhanced. This can be appreciated from Figure 8, where the difference spectra 
(between the start and end of the steady-state as illustrated in Fig. 7B) are compared for all 
variants. A clear trend in the drift toward the ferric form during steady-state may be 
discerned, in the order of Y48H (9.5 %) > G41S (3.5 %) > A51V (2.2 %) > WT (1.5 %). This 
order is the same as that already seen in the values of the Met80 dissociation rate constants 
(k1) determined from N3
–














The A51V substitution is located in a regular secondary structure motif (2-helix), in contrast 
to the disease causing mutations at the 41 and 48 positions, which lie on a region of the 40-57 
-loop devoid of secondary structure (Fig. 1). The -helix in hCc has the sequence 
TAA
51
NKNK, with Ala51 found at the N + 3 position. It is well documented that Ala has the 
highest helix propensity and is thus the most stabilising residue within an -helix.[62] Val on 
the other hand is considered to be a destabilizing residue in an -helix, with an estimated free 
energy difference (G) from Ala (which is arbitrarily set at G = 0.0 kcal/mol) of 0.61 
kcal/mol.[62] This destabilizing effect arises from an unfavourable change in side-chain 
conformational entropy when a helix is formed, with the loss greatest for amino acids with 
branched -carbons allowing only the trans conformation in folded states.[63, 64] Globally, 
at least, the Ala to Val mutation causes the native structure to be destabilised to a similar 
degree as the G41S variant (Table 1), with the decreasing 222/208 nm ratio having implications 
for a dynamic structure, relative to the WT protein. Based on helical-helical interactions 
within coiled-coil systems, a 222/208 nm ratio of > 1.1 is indicative of quaternary structure 
formation (i.e. two -helical monomers interacting) with 222/208 nm ratios of 0.9 or less being 
indicative of isolated helices.[65-67] Moreover for helical proteins, the 222/208 nm ratio can be 
associated with interhelical contacts and therefore can provide low-resolution information as 
to whether mutations cause a ‘loosening’ of the structure.[49] Based on our previous NMR 
studies to probe main chain dynamics in the WT protein and the G41S and Y48H variants,[5, 
31] the 222/208 nm ratios appear to correlate, in that the G41S was determined by NMR to be 
more dynamic than the WT, b t less dynamic than the Y48H variant. Therefore based on the 
222/208 nm ratio we suggest under non-denaturing conditions that the A51V variant is closer 
dynamically to the G41S variant than the Y48H variant.   
The m-value from chemical denaturation experiments is generally considered to give 
an estimate of the compactness or the degree of residual structure in the denatured state.[68, 
69] Table 1 reveals the m-value for the WT and variants decreases in the order WT > A51V  
G41S > Y48H. In yeast iso-1-Cc the m-value for the K54H variant is decreased relative to the 
WT protein [70] and this has been attributed to ligation by the His to the heme in the 
denatured state constraining the polypeptide and causing a more compact denatured state.[70] 
Neither the A51V or the G41S variants have substitutions that can coordinate the heme, yet 
in both cases the m-values decrease and notably more so than for substitutions in the 71-85 












destabilizing the 40-57 -loop (the lowest energy foldon of Cc), resulting in a more compact 
denatured state. A similar suggestion may be put forward for the Y48H variant, particularly 
now that by introducing a His this variant may behave similarly to the K54H variant of yeast 
iso-1 Cc.[70] However, the m-value for the Y48H variant is further decreased in respect to 
the A51V and G41S variants.[5] Solution state NMR studies under non-denaturing conditions 
with the Y48H variant are consistent with the presence of a partially unfolded form populated 
under non-denaturing conditions that bears the hallmarks of having an unfolded -helix.[5] 
The m-value can also infer the occurrence of intermediates on the unfolding pathway.[71-73] 
For example, the decreased m-value of the K73H variant of yeast iso-1 Cc was not ascribed 
to His-heme ligation in the denatured state as for the K54H variant,[70] but rather to the 
existence of a native-like unfolding intermediate at low denaturant concentrations.[72] 
Notably, solution NMR studies with the G41S variant, albeit indicative of increased 
dynamics relative to WT hCc,[31] are not consistent with a partially unfolded state populated 
under non-denaturing conditions. Therefore, it is likely that the m-value for the G41S and the 
A51V variants reflect more compact denatured states, whereas the much lower m-value 
determined for the Y48H variant is consistent with the presence of a native-like intermediate 
accessible under non-denaturing conditions, with consequences for peroxidase activity.  
The Met80-off rate for the A51V variant estimated from N3
–
 binding kinetics lies 
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K). Thus based on the low Kapp (high affinity for N3
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Kapp is identical to the ratio for the Y48H variant indicating that the K values are 
similar and hence the population of the pentacoordinate forms in these two variants at 
equilibrium are equivalent. In spite of this, the peroxidase activity, while enhanced for the 
A51V variant is not at the Y48H level,[5] or for that matter the G41S variant,[5] where from 




Kapp the population of the G41S pentacoordinate form is lower.[31] 
Therefore, we suggest that the observed trend in peroxidase activity between variants is not 
purely a consequence of the population of the pentacoordinate form, but rather the rate 
constant (i.e. Met80-off rate, k1) for accessing the pentacoordinate state is a dominant factor 
(k1 values WT < A51V  G41S < Y48H). In contrast, there is a lack of correlation between 
kf1 (the rate of formation of the alkaline form, Table 2) and k1, albeit that the transition to the 












determining step in the alkaline transition is not the Met80-off rate but rather subsequent 
steps involving the conformational transition and Lys binding to the ferric heme.  
Based on the above discussion the extent to which the native ferric hCc structure can 
facilitate peroxidase activity in these disease variants must be reconciled as an interplay 
between the Met80-off rate and tertiary structure dynamics. This view is further enhanced 
through recent studies with horse Cc using chemical denaturants to investigate peroxidase 
activity and ligand binding.[74] For the A51V and G41S variants the peroxidase activity 
whilst higher than WT hCc does not attain the Y48H variant levels, despite the 
pentacoordinate state of the A51V variant being populated to the same extent as the Y48H 
variant. In the case of the latter the increased Met80-off rate and a highly dynamic solution 
state with ease of access to an unfolded state in which the 40-57 and 71-85 -loops are 
highly perturbed[5] contribute to the higher peroxidase activity.  
Further insight into the peroxidase function of the variants may be obtained from the 
kinetics of the alkaline transition and the mechanistic framework in which four 
pentacoordinate forms can in theory be populated and illicit peroxidase activity (see the four 
corners of the front face of the cube in Figure 9 of Deacon et al.[25]). For the A51V variant 
the pKa and the pKH1 values are essentially the same as the G41S and Y48H variants, 
implying greater ease of access to the pCc-H species (Scheme 2). As a Lys will be more 
protonated at pH 6.5, where peroxidase assays were monitored, this pentacoordinate species 
(pCc-H) will be more populated at equilibrium than the WT hCc.  
The interpretation of the second ionisation (pKH2) of the alkaline transition in relation 
to peroxidase activity is more difficult. For the A51V variant the pKH2 value is higher by ~ 
0.5 pH units than either the G41S and Y48H variants (Fig. 5C).[25] The group we and others 
have previously suggested to be responsible for stabilization of this HS form by 
deprotonation, is the proximal His18, which can lose a proton at high pH in the G41S and 
Y48H variants, but cannot do so in the WT hCc in the accessible pH range.[25] Bowler and 
colleagues have reported the existence of a water channel as a result of a repositioning of the 
40-57 -loop in a non-native state of Cc, allowing access to the proximal His18 ligand.[15] 
The pH profile in Figure 5C suggests that loss of a proton to the bulk solution is more 
difficult for the A51V variant than either the G41S or Y48H variants [25] yielding a higher 
pKH2. Although the A51V and Y48H variants have similar fractions of the ferric protein in 
the pentacoordinate state, the ease of which these forms can be stabilized by deprotonation 












different. An explanation for this could manifest from differences in dynamics on the 
proximal side of the heme. We note that the substitutions at the 41 and 48 positions are at a 
juxtaposition to the 20’s -loop compared to the 51 position (Fig. 1). It has been well 
documented that the disruption of a hydrogen-bond between His26 and Pro44 causes the 
subsequent release of the 20’s and 40’s -loops leading to His18 being more accessible.[75] 
It could therefore be that the G41S and Y48H variants are more prominent than the A51V 
variant in perturbing this interaction and as a consequence instil a more dynamic proximal 
His side of the heme accounting for the subtilties in stabilizing the HS form of the G41S and 
Y48H variants over the A51V variant, with consequences for H2O2 access.   
Whilst extensive in vitro studies have been conducted on the hCc disease variants 
focusing on their apoptotic function, the effect of these mutations on respiratory chain 
function in vitro is lacking. From in vivo studies both the G41S and Y48H variants have been 
reported to induce a small defect in respiratory function based on measuring O2 consumption 
in cellular assays.[39] However, these studies do not report on the steady-state ratio of 
ferric/ferrous Cc when in turnover with CcO, which from the present and previous studies 
would be expected to vary in the disease variants When oxidised hCc and its variants are 
initially in the acid ferric form, i.e. the hexacoordinate (His/Met) conformer that possesses a 
695 nm absorption band. Thereafter the ferric protein comes into conformational equilibrium 
between the acid and alkaline forms, the proportions of which depend on the ambient pH and 
the apparent pKa of the alkaline transition. The WT hCc has an apparent pKa of 9.3 (Table 2) 
while all the disease associated variants have apparent pKa values ~ 1 pH unit lower. Thus, at 
pH 7.4 (experimental pH of the turnover assay), approximately 1 % of the WT and 10 % of 
the variants should, at equilibrium, be in the alkaline form. This means that in turnover 
experiments, as illustrated in Fig. 7, there will be a thermodynamic driving force towards the 
ferric alkaline form (1 % WT and up to 10 % for the variants), which cannot be reduced by 
ascorbate until, in the dynamic equilibrium, it returns to the acid form that can be reduced. 
Similarly, in vivo reduction of the alkaline form by the bc1 complex occurs at the rate of 
transition from alkaline to acid forms of Cc. The extent to which this happens is dependent 
not only on the pKa for the alkaline transition but also on the electron flux through the 
respiratory chain, for example in circumstances in which the Cc is held in the ferrous state, 
then no alkaline form of the ferric protein is present. The experimental results are consistent 
with this expectation, except that not all the variants populate the alkaline form to the same 












true equilibrium and the rate of approach to this equilibrium is variant dependant. The 
relaxation time () of the equilibrium between the acid and alkaline forms i.e. 1/ = kf1 + kb1 
is variant dependent and controls the kinetics of the approach to equilibrium and hence the 
extent to which the alkaline form is populated. These results therefore demonstrate that the 
disease related variants of hCc can have measurable effects on the mitochondrial electron-
transfer system. The magnitude of any such effect must depend on the redox state of hCc and 
hence on the energetic state of the cell (i.e. coupled/uncoupled respiration) and on the time of 
residence of any given molecule of hCc in the ferric state. These complex interactions cannot 
be readily assessed, but the overall effect of the 40-57 -loop variants is clear. Thus, 
although not as important as the well documented effects such as enhanced peroxidase 
activity it is worth pointing out that such mutations may have small but possibly significant 
effects on the overall energetics of the cell. Within this context we see that A51V perturbs the 
redox state to a minor degree compared to the G41S and Y48H variants. 
 
CONCLUSIONS 
From in vitro studies all three hCc variants display physicochemical properties of the ferric 
form that influence peroxidase activity. The A51V variants displays features that we believe 
are consistent with a less dynamic native state than the Y48H variant, and is closer in 
dynamic properties to the G41S variant. Notably the A51V variant stands out in that despite 
having a population of the pentacoordinate form equal to the Y48H variant, peroxidase 
activity is the lowest of the three variants; a result we ascribe to the lower Met80 off-rate and 
subtle variations in main chain dynamics caused at the different mutation sites. The clinical 
features of the families expressing the G41S and Y48H variants both show similar reduced 
mean platelet counts with normal platelet volume and function.[76] However, the A51V 
family, whilst also displaying reduced mean platelet counts has in addition a platelet function 
defect.[76] Thus a distinction in clinical phenotypes between the G41S and Y48H variants 
versus the A51V variant is evident and may correlate to some of the physicochemical 
properties we elucidate here. The excursion into assessing the in vitro respiratory properties 
through monitoring the steady-state ratio of ferric/ferrous Cc when in turnover with CcO has 
illustrated that mitochondrial respiration can be compromised by mutations in the 40-57 -
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SUPPORTING INFORMATION 
Figure S1 illustrative reaction time courses at 550 nm for human cytochrome c turnover with 
cytochrome c oxidase. Table S1 reports the extinction coefficient at 409 nm for human 
cytochrome c and the 40-57 -loop variants. 
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Table 1: Summary of thermodynamic and kinetic parameters for ferric WT hCc and the three 
40-57 -loop variants determined by GuHCl denaturation (15 
o
C, 10 mM potassium 
phosphate, 50 mM potassium fluoride pH 6.5) and azide binding kinetics (25 
o
C, 50 mM 
MES pH 7.0).  
 
GuHCl denaturation 















A51V 6.99 ± 0.16 3.66 ± 0.71 3.02 ± 0.07 2.32 ± 0.05 
G41S 6.75 ± 0.10
a 




Y48H 5.09 ± 0.16
a 




WT 10.65 ± 0.55
a 




Azide binding kinetics 
 




























Values taken from ref. 5. 
b
Values taken from ref. 31. 
c
Data taken from ref. 5 and refitted in the present study. 
d
For the A51V and Y48H variants, k-2 has been fitted using equation 4, and thereafter fixed to determine the 
errors on k1 (also using equation 4 with values reported in Table 1, see Materials and Methods). In addition, we 
have used the range of k-2 values reported in Table 1 to provide alternative commentary on the k1 errors. Thus 
for the A51V variant the range of k-2 yielded values of k1= 23 ± 8 s
-1
 (lower bound) and k1 = 64 ± 79 s
-1
 (upper 
bound). Likewise for the Y48H variant, k1 = 124 ± 49 s
-1
 (lower bound)and k1 = 329 ± 318 s
-1
 (upper bound). As 
k-2 and k1 are hyperbolically related, then we see as expected values of k-2 approaching its asymptotic value of 
11.8 ± 0.6 s
-1
 (see text), the error in k1 becomes large i.e. near the asymptotic value of k-2, small changes in k-2 













Table 2: Summary of parameters determined for the alkaline transition of ferric WT hCc and 
the three 40-57 -loop variants. 
 
 WT  A51V G41S Y48H 
pKa 9.3 ± 0.2
a






pKH1 12.0 ± 0.4
b 






) 17 ± 13
b 








0.034 ± 0.060 0.027 ± 0.012 0.084 ± 0.055 0.074 ± 0.051 
a
Data taken from ref. 5. 
b
Data taken from ref. 25. 
c
kb1 was calculated from Kc (pKc = pKH1 – pKa) as kb1 = Kckf1. The error on kb1 was calculated from the error on 
















Figure 1: X-ray structure of hCc (3ZCF)[23] and the location of the THC4 causing variants. 
The 40-57 -loop (beige) showing the three residues, Gly41, Tyr48 and Ala51, depicted in 
stick representation, that are mutated to Ser, His and Val, respectively. The position of 
Lys100 in the C-terminal helix is indicated in yellow. The heme and the axial iron ligands are 

















Figure 2: Far-UV CD spectroscopy and chemical denaturation. A) Far-UV CD profile of the 
ferric A51V variant of hCc compared to the profiles for the WT protein and the G41S and 
Y48H variants (pH 6.5 and 15 
o
C). B) Plot of the fraction unfolded versus GuHCl 
concentration for the ferric A51V hCc variant (pH 6.5, 15 
o
C) with the solid-line representing 
a fit to the data using a two-state equilibrium unfolding equation (see Materials and 
















Figure 3: Azide binding to the ferric A51V variant of hCc compared with data for the WT 
protein and G41S and Y48H variants[23, 31] at pH 7.0 and 25 
o
C. A) Amplitude changes 
from the reaction time-courses obtained using stopped-flow absorption spectroscopy at 420 
nm plotted against azide concentration. Data are fitted to a hyperbola to yield Kapp values 
reported in Table 1. B) Rate constants (kobs) determined for azide binding with solid lines 
representative of fits to equation 4 with k1 and k-2 values reported in Table 1. C) The 
relationship between the azide dissociation rate constant (k-2) and the Met80-off rate (k1) with 
















Figure 4: Peroxidase activity at pH 6.5. The maximum peroxidation rates of ABTS with the 
various forms of ferric Cc. The error bars are the standard error from measurements carried 

















Figure 5: The alkaline transition of the ferric A51V variant. A) The decrease in absorbance 
at 695 nm plotted as a function of pH, with the solid-line representative of a fit to the data 
using a one-proton equilibrium equation with apparent pK695 values reported in Table 2. B) 
The pH dependence of kobs1 for the slow phase of the alkaline transition for WT hCc and the 
three 40-57 -loop variants determined from pH jump experiments. The lines are fits to the 
logarithmic transformation of equation 5 to yield the pKH1 (Table 2). C) The pH dependence 
of kobs2 for the alkaline transition plotted as a function of pH. The solid lines through the data 
points for hCc, and the A51V variant indicates the trends in the data, whereas for the G41S 
and Y48H variants the solid line represents a combined fit to a one-proton equilibrium 















Figure 6: pH jump kinetics for the fast phase of the ferric A51V hCc variant at pH > 10.5. A) 
Single wavelength stopped-flow trace together with fit to a double-exponential on mixing 
ferric A51V hCc (pH 7) with an equal volume of a pH 11 buffer. The residuals of the double-
exponential fit are illustrated. B) Optical transitions between 480 and 700 nm from stopped-
flow spectroscopy taken at the indicated time during the pH jump experiment initiated as in 
(A). At t = 2.5 ms the spectrum represents the ferric hexacoordinate A51V variant, at t = 20 
















Figure 7: Redox states of hCc in turnover with CcO. A) Spectra collected at indicated times 
for the reactions of hCc (10 M) in the presence of CcO (2.5 M heme a), ascorbate (5 mM), 
TMPD (118 M) and 135 M oxygen ( all concentrations after mixing), pH 7.4 and 25 
o
C. 
B) The time course collected at 550 nm (-band of ferrous hCc) showing the approach to 
steady-state, and exit from steady-state. C) Difference spectrum between spectra taken at 2 s 

















Figure 8: Comparison of difference spectra (2 s - 22 s) collected at pH 7.4 and 25 
o
C for the 
WT hCc and disease related variants. Each variant spectrum was normalised to a WT 
spectrum taken on the same day under the same conditions. The spectra have been adjusted to 
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Comparison of the percentage of ferric cytochrome c approached in turnover with oxidase 
and the peroxidase activity of human cytochrome c and variants. The congruence follows 
from the underlying mechanism of Met80 dissociation. The proapoptotic cytochrome c 

















 Four pathogenic human cytochrome c variants have been discovered 
 Three are located in the 40-57 -loop: G41S, Y48H and A51V 
 The dynamic and electron-transfer properties of the A51V variant have been studied 
 Met80 off-rate plays a controlling role in the functions of the -loop variants  
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